Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advancis Surgical is a UK medical device company focused on operating-room blood management technologies. The business was launched in 2012 as a surgical brand/platform within Brightwake and commercializes Hemosep, a cell salvage and blood concentration system designed to recover blood lost during surgery and return concentrated autologous blood components to the patient. Its products are aimed primarily at cardiac and other major surgical specialties where reducing allogeneic transfusion requirements and postoperative bleeding is important. The company appears to operate as a trading brand or division of Brightwake rather than as a standalone listed biotech or pharmaceutical company. Overall, Advancis Surgical is a commercial-stage healthcare device business centered on perioperative blood recycling and transfusion efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advancis Surgical.